Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Aniracetam | Pramiracetam | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 750-1500 mg/day divided into 2-3 doses | 400-1200 mg/day divided into 2-3 doses |
| Timing | With fat-containing meals (fat-soluble compound; bioavailability increases significantly with dietary fat) | With fat-containing meals (fat-soluble). Morning and early afternoon dosing preferred. |
| Cycle Duration | Cycles of 8-12 weeks on, 4 weeks off | Cycles of 8-12 weeks on, 4 weeks off |
| Evidence Level | moderate_human | moderate_human |
Potent positive allosteric modulator of AMPA receptors with 5-10x the potency of piracetam, slowing both channel closing rate and microscopic desensitization rates. Also modulates metabotropic glutamate receptors (mGluRs), activates nicotinic acetylcholine receptors, and indirectly boosts dopaminergic and serotonergic neurotransmission, conferring anxiolytic properties.
750-1500 mg/day divided into 2-3 doses
With fat-containing meals (fat-soluble compound; bioavailability increases significantly with dietary fat)
Cycles of 8-12 weeks on, 4 weeks off
Potently stimulates high-affinity choline uptake (HACU) in hippocampal synaptosomes, the rate-limiting step in acetylcholine synthesis. This profoundly enhances cholinergic neurotransmission without direct receptor agonism. Approximately 10-30x more potent than piracetam on a per-milligram basis. Does not significantly affect other neurotransmitter systems, making it a highly targeted cholinergic enhancer.
400-1200 mg/day divided into 2-3 doses
With fat-containing meals (fat-soluble). Morning and early afternoon dosing preferred.
Cycles of 8-12 weeks on, 4 weeks off
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →